Floatz logo

Gerpevir

Herpes Simplex Infectious Disease

National Center for Research Resources (NCRR)Small moleculePhase 3Dormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Herpes Simplex Infectious Disease cohort.

Asset / SponsorPhaseRating
Valaciclovir
Hugo Lovheim
Phase 4BBB

Same molecule, other indications

Gerpevir is also rated in:

herpes zosterDormant
BB
Indicative · Phase 4
68 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative · Phase 4
68 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →